Diagnosis of tuberculosis infection using interferon-γ-based assays (Q37855146)

24 August 2017

1 reference

title

Diagnosis of tuberculosis infection using interferon-γ-based assays (English)

1 reference

24 August 2017

0 references

0 references

Miguel Santín Cerezales

series ordinal

1

1 reference

PubMed ID

21420564

24 August 2017

José Domínguez Benítez

series ordinal

2

1 reference

24 August 2017

1 March 2011

1 reference

Infectious Diseases and Clinical Microbiology

24 August 2017

1 reference

24 August 2017

29 Suppl 1

1 reference

24 August 2017

26-33

1 reference

Clinical practice. Latent tuberculosis infection

24 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Priorities for the Treatment of Latent Tuberculosis Infection in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Specific immune-based diagnosis of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

The booster effect in two-step tuberculin testing among young adults in Montreal

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Evaluation of the interferon-gamma release assay in healthcare workers

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Mycobacterium tuberculosis Infection in Health Care Workers in Rural India

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Performance of Tests for Latent Tuberculosis in Different Groups of Immunocompromised Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Prospective evaluation of latent tuberculosis with interferon-gamma release assays in drug and alcohol abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Crohn's disease: a review of current treatment with a focus on biologics.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Role of the T-cell interferon-gamma release assays in preventing reactivation of latent tuberculosis infection in immunosuppressed patients in treatment with anti-TNF agents

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Screening for tuberculosis infection prior to initiation of anti-TNF therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Interferon gamma assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

T cell-based diagnosis of childhood tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Interferon- release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Valor de QuantiFERON-TB Gold Test in Tube en el diagnóstico de tuberculosis pulmonar y extrapulmonar

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

QuantiFERON TB-2G test for patients with active tuberculosis stratified by age groups

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Ex Vivo Characterization of Early Secretory Antigenic Target 6-Specific T Cells at Sites of Active Disease in Pleural Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Novel tests for diagnosing tuberculous pleural effusion: what works and what does not?

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Use of a T-cell interferon- release assay for the diagnosis of tuberculous pleurisy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON TB-Gold interferon-gamma assay

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Utility of quantitative T-cell responses versus unstimulated interferon-{gamma} for the diagnosis of pleural tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Diagnosis of central nervous system tuberculosis by T-cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Rapid diagnosis of tuberculous meningitis by T cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Is the whole-blood gamma interferon assay better than the tuberculin skin test in predicting active tuberculosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Detection of latent tuberculosis by the tuberculin skin test and a whole-blood interferon-γ release assay, and the development of active tuberculosis in HIV-seropositive persons

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Use of QuantiFERON-TB Gold to investigate tuberculosis contacts in a high school

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

T-cell interferon- release assays: can we do better?

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Interferon gamma release assays: principles and practice

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970015-5

7 January 2021

10.1016/S0213-005X(11)70015-5

Identifiers

DOI

1 reference

release_44vyuzr56ne2jfquym5ireb7zi

24 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/44vyuzr56ne2jfquym5ireb7zi

24 November 2022

mapped directly with Wikidata item

PubMed ID

21420564

1 reference

PubMed ID

21420564